Observed arrival · 2026-11-05
A status board for dog-longevity drugs
Dog Longevity Pills tracks FDA review steps, trial progress, and stated age and weight ranges for several drugs being studied to extend dogs’ lives.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Dog owners following longevity-drug research
- Worth noticing
- The page lists LOY-002’s STAY study as 1,300 dogs across 72 U.S. veterinary clinics, with results not expected before late 2027.
Field notes
The tracker separates effectiveness, safety, and manufacturing into distinct review steps, with dates attached to accepted steps and labels for work still in progress or waiting. Its trial section lists STAY at 1,300 dogs across 72 U.S. veterinary clinics, and TRIAD as a recruiting study of 580 dogs. A separate section compares seven supplements, while the page cautions that none is FDA-approved or has shown longer life in dogs.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
One card from the complete issue